WFH: World Federation of Hematology

Conference Coverage

Therapy can extend half-life of FVIII

GLASGOW—Preliminary data suggest an investigational therapy can extend the half-life of factor VIII (FVIII) in patients with severe hemophilia A...

Conference Coverage

Hemophilia may not be protective against CVD

Key clinical point: Hemophilia has traditionally been considered protective against CVD but data presented at the World Federation of Hemophilia...